Table 1.

Patient characteristics

			Medical history
Patient	Sex	Age, y	Hemopathy	Neoplasia	Others	Immunosuppression	Cause of HPS	Evolution
1	F	48	No	No	No	CS	Parasite infection	Favorable
2	M	15	No	No	No	No	Viral infection	Favorable
3	F	86	No	Colon	Dermatomyositis	CS	Bacterial infection	Death
4	M	42	No	No	No	No	Viral infection	Favorable
5	F	55	No	No	Still disease	CS and CP	Bacterial infection	Favorable
6	M	39	No	No	No	Chronic ethylic intoxication	Infection (K pneumoniae)	Favorable
7	M	59	No	No	No	No	Viral infection	Favorable
8	M	81	No	No	No	No	Viral infection (HSV)	Favorable
9	F	83	No	No	No	No	Non-Hodgkin lymphoma	Death
10	M	83	No	Prostate	No	No	Metastatic neoplasia	Death
11	M	58	No	No	No	Chronic ethylic intoxication	Viral infection	Favorable
12	F	77	No	No	No	No	Non-Hodgkin lymphoma	Death
13	M	62	No	No	No	No	Viral infection (VZV)	Favorable
14	M	62	No	No	No	No	Non-Hodgkin lymphoma	Death
15	M	50	CLL	No	No	No	Bacterial infection	Favorable
16	F	37	No	No	AIHA	No	Viral infection	Favorable
17	F	62	No	No	No	No	Viral infection	Favorable
18	M	61	No	No	No	No	Nonidentified	Favorable
18 bis	No	No	No	No	Nonidentified	Favorable
19	F	44	No	No	Chronic hepatitis C	No	Nonidentified	Death
20	F	41	No	No	SLE/RA/APS	CS and splenectomy	Bacterial infection	Favorable

F indicates female; CS, corticosteroids; M, male; CP, cyclophosphamide; K pneumoniae, Klebsiella pneumoniae; HSV, herpes simplex virus; VZV, varicella zoster virus; CLL, chronic lymphoid leukemia; AIHA, autoimmune hemolytic anemia; SLE, systemic lupus erythematosus; RA, rheumatism arthritis; and APS, antiphospholipid syndrome.